Results 151 to 160 of about 1,546 (196)

Peculiarities of implantation of the right graft veins into the inferior vena cava during living donor liver transplantation. [PDF]

World J Transplant
Beridze D, Mikeladze L, Tomadze G, Kordzaia D, Kashibadze K.   +4 more
europepmc   +1 more source

Risk of Postoperative Hypermagnesemia in Cardiopulmonary Bypass-Assisted Cardiovascular Surgery. [PDF]

Kidney360
Ghaddar M, Hatab T, El-Kaakour A, Tamim H, Makki M, El-Halabi T, Rifaii K, Sfeir P, Hoteit M, Koubar SH.   +9 more
europepmc   +1 more source

Myocardial protection: comparing histological effects of single-dose cardioplegic solutions-study protocol for a secondary analysis of the CARDIOPLEGIA trial. [PDF]

J Thorac Dis
Lira KB, Delvaux RS, Spadini FA, Hauschild LH, Ceron RO, Anschau F, Kopittke L, Rode J, Rey RAW, Wittke EI, Rombaldi AR, Cambruzzi E, Lopes ERC, Almeida AS.   +13 more
europepmc   +1 more source

Temporary Passive Shunt for Visceral Protection During Open Thoracoabdominal Aortic Repair Under Intraoperative Advanced Hemodynamic and Perfusion Monitoring: Tertiary Hospital Institutional Bundle and Preliminary Mid-Term Results. [PDF]

J Clin Med
Borghese O, Minucci M, Jacchia E, Annuvolo PA, Scurto L, Luparelli A, Russo A, Aceto P, Donati T, Tshomba Y.   +9 more
europepmc   +1 more source

Development and validation of a checklist for cardiopulmonary bypass. [PDF]

J Extra Corpor Technol
Assis Dos Reis Filho V, Aparecida Antonelli Novello K, Matias ML.   +2 more
europepmc   +1 more source

Surgical Management of a Ruptured Giant Left Main Coronary Artery Aneurysm Presenting with Cardiac Tamponade. [PDF]

Diagnostics (Basel)
Shumakov D, Zybin D, Stepanova E, Dabravolski S, Sigaleva E, Silina E, Stupin V, Popov M.   +7 more
europepmc   +1 more source

Custodiol-N versus Custodiol: a prospective randomized double-blind multicentre phase III trial in patients undergoing elective coronary bypass surgery

European Journal of Cardio-thoracic Surgery, 2022
Abstract OBJECTIVES HTK-Solution (Custodiol) is a well-established cardioplegic and organ preservation solution. We currently developed a novel HTK-based solution, Custodiol-N, which includes iron chelators to reduce oxidative injury, as well as l-arginine, to improve endothelial ...
Gabor SZABÓ, Paige Brlecic, Sivakkanan Loganathan   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Improving hemocompatibility of decellularized liver scaffold using Custodiol solution

Biomaterials Advances, 2022
Organ decellularization is one of the most promising approaches of tissue engineering to overcome the shortage of organs available for transplantation. However, there are key hurdles that still hinder its clinical application, and the lack of hemocompatibility of decellularized materials is a central one.
Marlon Lemos Dias, Fabio C S Nogueira, Gilberto B Domont   +2 more
exaly   +3 more sources

Custodiol for myocardial protection and preservation [PDF]

QJM - Monthly Journal of the Association of Physicians, 2020
Abstract Introduction Custodiol cardioplegia is attractive for minimally invasive cardiac surgery, as a single dose provides a long period of myocardial protection. Despite widespread use in Europe, there is little data confirming its efficacy compared with conventional (blood or crystalloid ...
A H Omar, Y Elnahhas, A B Elkerdany, M A Gobran   +3 more
exaly   +2 more sources

Custodiol cardioplegia for temporary mechanical circulatory support

Perfusion, 2023
Several patients requiring biventricular mechanical circulatory support in the acute setting will not be candidates for less invasive advanced heart failure therapies not requiring median sternotomy. Temporary biventricular assist device may provide reliable short term support bridging patients to recovery or further advanced treatments.
Charlene Tennyson, Stuart Grant, Bobby HN Chow, Mazin AI Sarsam, Isaac Kadir, Ioannis Dimarakis   +5 more
openaire   +2 more sources